Filed: 2/14/2024ACC: 0001420506-24-000473
📋 What this filing means
IKARIAN CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 101 equity positions with a total reported market value of $1.07B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
101
Positions
$1.07B
Total AUM (reported)
49.66M
Total Shares
Allocation by class
COM$694.65M65.0%
COM NEW$104.65M9.8%
SPONSORED ADR$85.96M8.0%
S&P BIOTECH$49.11M4.6%
NAMEN AKT$45.31M4.2%
SHS$40.30M3.8%
S&P HOMEBUILD$19.13M1.8%
Portfolio Concentration
Top 3$202.66M19.0%
4–10$295.84M27.7%
11–25$316.10M29.6%
Rest$253.39M23.7%
Top 3 weight
19.0%
Top 10 weight
46.7%
Voting Authority Distribution
Total shares with voting rights: 49.66M
Sole
Full voting authority
49.66M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole101
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings101
Rows:
ARGENX SE
SOLEShares226.20K
TypeSH
Market value$85.96M
8.05%
Sole
226.20K
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares512K
TypeSH
Market value$63.52M
5.95%
Sole
512K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares637K
TypeSH
Market value$53.18M
4.98%
Sole
637K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares268.30K
TypeSH
Market value$51.36M
4.81%
Sole
268.30K
Shared
0.00
None
0.00
SPDR SER TR
SOLEShares550K
TypeSH
Market value$49.11M
4.60%
Sole
550K
Shared
0.00
None
0.00
CRISPR THERAPEUTICS AG
SOLEShares723.85K
TypeSH
Market value$45.31M
4.24%
Sole
723.85K
Shared
0.00
None
0.00
ELI LILLY & CO
SOLEShares70K
TypeSH
Market value$40.80M
3.82%
Sole
70K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares417.04K
TypeSH
Market value$40.22M
3.77%
Sole
417.04K
Shared
0.00
None
0.00
PROTHENA CORP PLC
SOLEShares1.02M
TypeSH
Market value$37.01M
3.47%
Sole
1.02M
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares2.18M
TypeSH
Market value$32.03M
3.00%
Sole
2.18M
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares410.94K
TypeSH
Market value$30.24M
2.83%
Sole
410.94K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares698.79K
TypeSH
Market value$29.44M
2.76%
Sole
698.79K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares780.37K
TypeSH
Market value$27.77M
2.60%
Sole
780.37K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares611.44K
TypeSH
Market value$24.61M
2.30%
Sole
611.44K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares1.04M
TypeSH
Market value$24.09M
2.26%
Sole
1.04M
Shared
0.00
None
0.00
ABBVIE INC
SOLEShares132.50K
TypeSH
Market value$20.53M
1.92%
Sole
132.50K
Shared
0.00
None
0.00
SPDR SER TR
SOLEShares200K
TypeSH
Market value$19.13M
1.79%
Sole
200K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares473.13K
TypeSH
Market value$19.10M
1.79%
Sole
473.13K
Shared
0.00
None
0.00
BIOMEA FUSION INC
SOLEShares1.28M
TypeSH
Market value$18.55M
1.74%
Sole
1.28M
Shared
0.00
None
0.00
KARUNA THERAPEUTICS INC
SOLEShares58.60K
TypeSH
Market value$18.55M
1.74%
Sole
58.60K
Shared
0.00
None
0.00
LANTHEUS HLDGS INC
SOLEShares285K
TypeSH
Market value$17.67M
1.65%
Sole
285K
Shared
0.00
None
0.00
CORCEPT THERAPEUTICS INC
SOLEShares542.60K
TypeSH
Market value$17.62M
1.65%
Sole
542.60K
Shared
0.00
None
0.00
ACELYRIN INC
SOLEShares2.33M
TypeSH
Market value$17.37M
1.63%
Sole
2.33M
Shared
0.00
None
0.00
IMMUNOGEN INC
SOLEShares546.96K
TypeSH
Market value$16.22M
1.52%
Sole
546.96K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares1.14M
TypeSH
Market value$15.21M
1.42%
Sole
1.14M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ARGENX SESOLE | SPONSORED ADR | 226.20K | SH | $85.96M 8.05% | 226.20K | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 512K | SH | $63.52M 5.95% | 512K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 637K | SH | $53.18M 4.98% | 637K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 268.30K | SH | $51.36M 4.81% | 268.30K | 0.00 | 0.00 |
SPDR SER TRSOLE | S&P BIOTECH | 550K | SH | $49.11M 4.60% | 550K | 0.00 | 0.00 |
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 723.85K | SH | $45.31M 4.24% | 723.85K | 0.00 | 0.00 |
ELI LILLY & COSOLE | COM | 70K | SH | $40.80M 3.82% | 70K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 417.04K | SH | $40.22M 3.77% | 417.04K | 0.00 | 0.00 |
PROTHENA CORP PLCSOLE | SHS | 1.02M | SH | $37.01M 3.47% | 1.02M | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 2.18M | SH | $32.03M 3.00% | 2.18M | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 410.94K | SH | $30.24M 2.83% | 410.94K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 698.79K | SH | $29.44M 2.76% | 698.79K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 780.37K | SH | $27.77M 2.60% | 780.37K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 611.44K | SH | $24.61M 2.30% | 611.44K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 1.04M | SH | $24.09M 2.26% | 1.04M | 0.00 | 0.00 |
ABBVIE INCSOLE | COM | 132.50K | SH | $20.53M 1.92% | 132.50K | 0.00 | 0.00 |
SPDR SER TRSOLE | S&P HOMEBUILD | 200K | SH | $19.13M 1.79% | 200K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 473.13K | SH | $19.10M 1.79% | 473.13K | 0.00 | 0.00 |
BIOMEA FUSION INCSOLE | COM | 1.28M | SH | $18.55M 1.74% | 1.28M | 0.00 | 0.00 |
KARUNA THERAPEUTICS INCSOLE | COM | 58.60K | SH | $18.55M 1.74% | 58.60K | 0.00 | 0.00 |
LANTHEUS HLDGS INCSOLE | COM | 285K | SH | $17.67M 1.65% | 285K | 0.00 | 0.00 |
CORCEPT THERAPEUTICS INCSOLE | COM | 542.60K | SH | $17.62M 1.65% | 542.60K | 0.00 | 0.00 |
ACELYRIN INCSOLE | COM | 2.33M | SH | $17.37M 1.63% | 2.33M | 0.00 | 0.00 |
IMMUNOGEN INCSOLE | COM | 546.96K | SH | $16.22M 1.52% | 546.96K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 1.14M | SH | $15.21M 1.42% | 1.14M | 0.00 | 0.00 |
Page 1 of 5
…